Enzolytics Inc (ENZC)

[OTCShotCaller]

Great question!

Here's the short answer:

Phase I - Several months

Phase II- Several months to 2-Years

Phase III - 1 to 4 years

Phase IV - Same as Phase III possibly longer.

Here's a helpful link to review:

https://www.clinicaltrialsandme.com/resources/how-long-do-clinical-trials-take.html

Please keep in mind these are only estimates AND that Enzolytics-BioClonetics will have to conduct ALL 4 Clinical Trial Phases to bring their drug to commercialization.

However the Market always reflects these developments in the Share Price!

For example, if you take a look at today's "Most Read" Stocks here on iHub, in the #1 position at the top is NorthWest Biotherapeutics (NWBO) presently trading at: $ 0.785.

If you go to this Company's website you will see that they are still in the drug development-clinical trial stages with no products on the market.

Here's a excerpt on the front page of their website and the Link to their Company:

"Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of cancer vaccines for treating a broad range of solid tumor cancers."

They presently have 4 candidate drugs in development and all 4 of them are in different stages of clinical trials that can be viewed on a chart posted on their website.

https://nwbio.com/

They are engaged in the FDA required Phase I-Phase IV clinical trial process and have four (4) candidate drugs they seek to bring to market listed on their website. As of today they have no drugs on the market, but soon they likely will.

Apparently they just completed Phase III of one of their candidate drugs that's transitioning to Phase IV; another is just entering Phase II; one is soon to enter Phase III; and one is entering Phase I.

https://nwbio.com/clinical-trials/

I hope this explanation helps as it is the same process that Endolytics-BioClonetics will be required to go through for FDA approval.

We're looking at several years before Endolytics-BioClonetics get their HIV/Anti-Viral drug to market.

Once Enzoltics-BioClonetics completes the U.C. Davis Primate Study, if that proves successful, they will quickly advance to Human Subject clinical trial Phase I and onward.

***General Note to ALL*** Everyone here needs to keep in mind that for the above reasons this is a long-term investment play.